Sponsor pipeline

Apollo Therapeutics Ltd clinical trial pipeline

Get alerts when Apollo Therapeutics Ltd's trials change

5 active trials 3 recruiting 10 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-14
notable
Enrollment closed, study ongoing
NCT06399757 A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · Phase 1/2

Active trials by phase

Early Phase 1
1
Phase 1
1
Phase 1/2
1
Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07599813 A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic… Atopic Dermatitis Recruiting 2026-08-12
NCT06846554 A Trial of "APL-9796'' in Adults With Pulmonary Hypertension Pulmonary Arterial Hypertension Recruiting 2026-05-11
Phase 1/2
NCT06399757 A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors Colorectal Cancer Active, Not Recruiting 2026-08-13
Phase 1
NCT06372717 A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS Acute Myeloid Leukemia Refractory Recruiting 2026-06-01
Early Phase 1
NCT07399132 A Study of APL-10456-Vaccine Rhinovirus Active, Not Recruiting 2026-05-27

Disease areas by active trials

Get alerts when Apollo Therapeutics Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free